X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (24043) 24043
Book Chapter (197) 197
Dissertation (159) 159
Magazine Article (72) 72
Web Resource (30) 30
Book / eBook (26) 26
Newsletter (25) 25
Publication (16) 16
Conference Proceeding (15) 15
Reference (9) 9
Streaming Video (6) 6
Newspaper Article (3) 3
Trade Publication Article (2) 2
Book Review (1) 1
Government Document (1) 1
Journal / eJournal (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (14653) 14653
dyslipidemia (13879) 13879
male (10047) 10047
female (9204) 9204
risk factors (7716) 7716
middle aged (7046) 7046
adult (5556) 5556
cholesterol (5158) 5158
aged (4696) 4696
obesity (4322) 4322
hypertension (3992) 3992
lipids (3970) 3970
metabolic syndrome (3664) 3664
diabetes (3650) 3650
dyslipidemias - drug therapy (3452) 3452
dyslipidemias - blood (3125) 3125
prevalence (3101) 3101
atherosclerosis (3015) 3015
dyslipidemias - epidemiology (2934) 2934
insulin resistance (2933) 2933
animals (2902) 2902
diabetes mellitus (2882) 2882
cardiovascular disease (2850) 2850
cardiovascular diseases (2764) 2764
dyslipidemias - complications (2624) 2624
risk (2613) 2613
dyslipidemias (2410) 2410
body mass index (2365) 2365
cardiac & cardiovascular systems (2362) 2362
endocrinology & metabolism (2307) 2307
insulin-resistance (2265) 2265
triglycerides (2246) 2246
lipids - blood (2242) 2242
cardiovascular-disease (2161) 2161
research (2138) 2138
triglycerides - blood (2134) 2134
lipoproteins (2125) 2125
coronary-heart-disease (2098) 2098
cholesterol, ldl - blood (2017) 2017
statins (1919) 1919
pharmacology & pharmacy (1899) 1899
disease (1885) 1885
cross-sectional studies (1862) 1862
metabolism (1862) 1862
cholesterol, hdl - blood (1807) 1807
mortality (1785) 1785
adolescent (1747) 1747
inflammation (1741) 1741
health aspects (1712) 1712
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (1700) 1700
treatment outcome (1686) 1686
medicine, general & internal (1638) 1638
blood pressure (1634) 1634
risk-factors (1595) 1595
glucose (1565) 1565
peripheral vascular disease (1533) 1533
medicine (1528) 1528
analysis (1500) 1500
prevention (1500) 1500
insulin (1490) 1490
biomarkers - blood (1484) 1484
cardiovascular diseases - prevention & control (1460) 1460
care and treatment (1436) 1436
young adult (1430) 1430
cholesterol - blood (1425) 1425
type 2 diabetes (1421) 1421
nutrition & dietetics (1416) 1416
hypolipidemic agents - therapeutic use (1410) 1410
hypertension - epidemiology (1391) 1391
diet (1379) 1379
association (1355) 1355
biochemistry & molecular biology (1354) 1354
cardiovascular diseases - etiology (1347) 1347
low density lipoproteins (1330) 1330
oxidative stress (1282) 1282
cardiovascular diseases - epidemiology (1265) 1265
dyslipidemias - metabolism (1232) 1232
mice (1229) 1229
aged, 80 and over (1203) 1203
metabolic disorders (1165) 1165
dyslipidemias - diagnosis (1157) 1157
risk assessment (1140) 1140
cardiovascular (1130) 1130
studies (1129) 1129
physiological aspects (1117) 1117
dyslipidemias - etiology (1114) 1114
hypercholesterolemia (1113) 1113
research article (1110) 1110
child (1106) 1106
comorbidity (1085) 1085
population (1081) 1081
retrospective studies (1077) 1077
lipid metabolism (1072) 1072
cardiovascular risk (1067) 1067
liver (1055) 1055
rats (1053) 1053
density-lipoprotein cholesterol (1026) 1026
blood-pressure (987) 987
time factors (966) 966
abridged index medicus (965) 965
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Online Resources - Online (16) 16
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
Gerstein Science - Stacks (3) 3
Scarborough Hospital - Online (2) 2
Mt Sinai Hospital - Online (1) 1
St. Michael's Hospital - Online (1) 1
St. Michael's Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (22560) 22560
Spanish (742) 742
Portuguese (651) 651
Russian (322) 322
French (302) 302
Japanese (270) 270
Chinese (211) 211
German (159) 159
Czech (123) 123
Polish (98) 98
Korean (88) 88
Italian (65) 65
Hungarian (32) 32
Turkish (27) 27
Romanian (18) 18
Slovak (14) 14
Ukrainian (14) 14
Persian (13) 13
Norwegian (12) 12
Lithuanian (11) 11
Croatian (8) 8
Serbian (7) 7
Swedish (6) 6
Danish (5) 5
Dutch (4) 4
Finnish (4) 4
Indonesian (4) 4
Slovenian (4) 4
Arabic (3) 3
Hebrew (3) 3
Breton (2) 2
Icelandic (2) 2
Belarusian (1) 1
Bosnian (1) 1
Bulgarian (1) 1
Galician (1) 1
Greek (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cardiovascular diabetology, ISSN 1475-2840, 2019, Volume 18, Issue 1, pp. 1 - 20
Journal Article
Atherosclerosis, ISSN 0021-9150, 2015, Volume 239, Issue 2, pp. 483 - 495
Abstract Cardiovascular disease (CVD) remains the leading cause of morbidity and mortality for patients with type 2 diabetes, despite recent significant... 
Cardiovascular | Type 2 diabetes | CVD | Fatty liver | Dyslipidemia | β-oxidation | Triglycerides | De novo lipogenesis (DNL) | CARDIAC & CARDIOVASCULAR SYSTEMS | DE-NOVO LIPOGENESIS | FATTY LIVER-DISEASE | B-CONTAINING LIPOPROTEINS | LOW-DENSITY-LIPOPROTEIN | TRIGLYCERIDE-RICH LIPOPROTEINS | STEAROYL-COA DESATURASE | beta-oxidation | HEPATIC INSULIN-RESISTANCE | PERIPHERAL VASCULAR DISEASE | CORONARY-HEART-DISEASE | GROWTH-FACTOR 21 | APOLIPOPROTEIN-C-III | Prevalence | Cardiovascular Diseases - prevention & control | Cholesterol - blood | Humans | Intestines - metabolism | Liver - physiopathology | Diabetes Mellitus, Type 2 - epidemiology | Dyslipidemias - blood | Cardiovascular Diseases - blood | Cardiovascular Diseases - epidemiology | Dyslipidemias - diagnosis | Cardiovascular Diseases - physiopathology | Dyslipidemias - drug therapy | Risk Assessment | Liver - metabolism | Risk Factors | Biomarkers - blood | Lipoproteins - blood | Diabetes Mellitus, Type 2 - diagnosis | Diabetes Mellitus, Type 2 - blood | Animals | Diabetes Mellitus, Type 2 - physiopathology | Dyslipidemias - epidemiology | Lipid Metabolism - drug effects | Triglycerides - blood | Hypolipidemic Agents - therapeutic use | Intestines - physiopathology | Blood Glucose - metabolism | Dyslipidemias - physiopathology | Blood lipids | Low density lipoproteins | Mortality | HEPATIC | ISCHEMIC-HEART-DISEASE | Peripheral Vascular Disease | Kardiologi | Cardiac and Cardiovascular Systems | NONALCOHOLIC FATTY LIVER | INSULIN-RESISTANCE | CORONARY-ARTERY-DISEASE
Journal Article
Atherosclerosis, ISSN 0021-9150, 2016, Volume 246, pp. 243 - 250
Abstract Objective Since dyslipidaemia is one of the most important risk factors for coronary heart disease (CHD), lowering of LDL-cholesterol (LDL-C) causes... 
Cardiovascular | LDL-Cholesterol | EUROASPIRE | Secondary prevention | Non-HDL-Cholesterol | Coronary heart disease | Statins | CARDIAC & CARDIOVASCULAR SYSTEMS | METAANALYSIS | LDL CHOLESTEROL | PERCEPTION | DENSITY-LIPOPROTEIN CHOLESTEROL | STATIN THERAPY | PREDICTORS | PERIPHERAL VASCULAR DISEASE | HDL-CHOLESTEROL | DYSLIPIDEMIA | PRIMARY PREVENTION | CARDIOVASCULAR RISK-FACTORS | Secondary Prevention - trends | Humans | Middle Aged | Patient Discharge | Coronary Disease - epidemiology | Male | Drug Utilization Review | Young Adult | Dyslipidemias - blood | Time Factors | Guideline Adherence - trends | Lipids - blood | Aged, 80 and over | Adult | Female | Drug Therapy, Combination | Dyslipidemias - diagnosis | Coronary Disease - blood | Dyslipidemias - drug therapy | Cross-Sectional Studies | Risk Assessment | Risk Factors | Europe - epidemiology | Treatment Outcome | Biomarkers - blood | Coronary Disease - diagnosis | Drug Prescriptions | Practice Patterns, Physicians' - trends | Dyslipidemias - epidemiology | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Adolescent | Coronary Disease - drug therapy | Aged | Healthcare Disparities - trends | Health Care Surveys | Practice Guidelines as Topic | Surveys | Medical research | Blood cholesterol | Cardiac patients | Low density lipoproteins | Mortality | Medicine, Experimental | Cardiovascular agents
Journal Article
Journal Article
PloS one, ISSN 1932-6203, 2016, Volume 11, Issue 4, p. e0153497
Non-alcoholic fatty liver disease (NAFLD) covers a spectrum of diseases from simple steatosis to non-alcoholic steatohepatitis, with approximately 20% risk of... 
DIAGNOSIS | AMERICAN ASSOCIATION | RECOMMENDATIONS | MULTIDISCIPLINARY SCIENCES | CONTROLLED ATTENUATION PARAMETER | MARKERS | STEATOHEPATITIS | MICRORNAS | HEPATIC STEATOSIS | EXPRESSION | PCR | Dyslipidemias - genetics | Up-Regulation | Liver - pathology | Cross-Sectional Studies | Dyslipidemias - complications | Non-alcoholic Fatty Liver Disease - genetics | Humans | Middle Aged | Male | Non-alcoholic Fatty Liver Disease - complications | Young Adult | Caenorhabditis elegans | Non-alcoholic Fatty Liver Disease - blood | Dyslipidemias - blood | Animals | Non-alcoholic Fatty Liver Disease - diagnosis | Adult | Female | MicroRNAs - blood | MicroRNAs - genetics | Dyslipidemias - diagnosis | Complications and side effects | MicroRNA | Fatty liver | Dyslipidemias | Physiological aspects | Genetic aspects | Research | Risk factors | Biotechnology | Correlation | Nuclear magnetic resonance--NMR | Transplants & implants | Liver | Dyslipidemia | Liver cancer | Hepatitis | Ultrasonic imaging | miRNA | Obesity | Liver diseases | Medical imaging | Feasibility studies | Inflammation | Metabolism | Gene expression | Patients | Low density lipoprotein | Cholesterol | Lipoproteins (very low density) | Steatosis | Serum levels | Cirrhosis | Weight control | Biopsy | MicroRNAs | Fibrosis | Biomarkers | Diagnostic systems | Diabetes | Methods | Nuclear magnetic resonance | NMR
Journal Article
Journal Article